AUTL Autolus Therapeutics

添加自選

4.190
+0.080+1.95%

收盤價 05/03 16:00 (美東)

4.220
+0.030+0.72%

盤後 16:53 (美東)

11.14億總市值-3491市盈率TTM

關於Autolus Therapeutics公司

Autolus Therapeutics PLC 是一家生物製藥公司，致力於開發用於治療癌症的下一代程序化 T 細胞療法。公司臨牀階段管線包括Obe-cel（obecabtagene autoleucel）、AUTO1/22、AUTO3、AUTO5、AUTO6、AUTO7和AUTO8。

公司介紹

公司代碼AUTL

公司名稱Autolus Therapeutics

上市日期2018/06/22

發行價格17.00

成立日期2018

CEODr. Christian Itin, PhD.

所屬市場納斯達克

員工數量471

證券類型存託憑證（普通股）

ADS轉換比例1.0 : 1.0

年結日12-31

公司地址The Mediaworks,191 Wood Lane,White City

城市倫敦

省份大倫敦

國家英國

郵編W12 7FP

電話44-20-3829-6230

網址http://www.autolus.com

董事高管

姓名
職務
年薪

Dr. Christian Itin, PhD.
Chief Executive Officer and Director
192.11萬

Dr. Christopher Willia PhD
Senior Vice President and Chief Business Development Officer
--

Dr. Edgar Braendle
Senior Vice President and Chief Development Officer
--

Robert F. Dolski
Senior Vice President, Chief Financial Officer
--

David Brochu
Senior Vice President and Chief Technical Officer
--

Christopher Vann
Senior Vice President and Chief Operating Officer
--

Alexander Swan
Senior Vice President, Chief Human Resources Officer
--

Brent Rice
Senior Vice President and Chief Commercial Officer
--

Martin Pule
Senior Vice President and Chief Scientific Officer
--

Michael W. Bonney
Chairman of the Board
--

Dr. Elisabeth Leiderman, M.D.
Director
1.27萬

Robert W. Azelby
Director
--

Dr. Ravi Rao, M.D.
Director
--

Linda C. Bain
Independent Director
16.95萬

Dr. Robert Iannone, M.D.
Independent Director
13.49萬

John E. Berriman
Independent Director
16.31萬

Dr. Martin Murphy, PhD
Independent Director
15.83萬

William D. Young
Independent Director
17.58萬

Dr. Joseph Anderson, PhD.
Independent Director
19.56萬

Cynthia M. Butitta
Independent Director
16.46萬

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

美股

綜合熱度